| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocrine Disruptors | 47 | 2021 | 78 | 13.020 |
Why?
|
| Thyroid Hormones | 48 | 2023 | 81 | 6.920 |
Why?
|
| Environmental Pollutants | 31 | 2020 | 97 | 6.480 |
Why?
|
| Thyroid Gland | 31 | 2022 | 83 | 4.810 |
Why?
|
| Environmental Exposure | 31 | 2021 | 228 | 4.750 |
Why?
|
| Phenols | 13 | 2024 | 77 | 3.690 |
Why?
|
| Benzhydryl Compounds | 13 | 2024 | 61 | 3.150 |
Why?
|
| Polychlorinated Biphenyls | 16 | 2021 | 39 | 3.070 |
Why?
|
| Brain | 34 | 2020 | 1672 | 2.780 |
Why?
|
| Prenatal Exposure Delayed Effects | 16 | 2022 | 155 | 2.460 |
Why?
|
| Thyroxine | 19 | 2021 | 53 | 2.230 |
Why?
|
| Receptors, Thyroid Hormone | 16 | 2019 | 27 | 2.140 |
Why?
|
| Antithyroid Agents | 10 | 2014 | 19 | 2.040 |
Why?
|
| Pregnancy | 56 | 2024 | 2411 | 1.690 |
Why?
|
| Hypothyroidism | 11 | 2024 | 42 | 1.610 |
Why?
|
| European Union | 8 | 2016 | 11 | 1.460 |
Why?
|
| Rats | 51 | 2019 | 2005 | 1.430 |
Why?
|
| Animals | 111 | 2021 | 21494 | 1.420 |
Why?
|
| Endocrine System | 5 | 2016 | 16 | 1.310 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2020 | 626 | 1.170 |
Why?
|
| Thyrotropin | 10 | 2023 | 34 | 1.130 |
Why?
|
| Triiodothyronine | 9 | 2021 | 30 | 1.120 |
Why?
|
| Toxicity Tests | 5 | 2020 | 19 | 1.080 |
Why?
|
| Propylthiouracil | 6 | 2019 | 8 | 1.070 |
Why?
|
| RNA, Messenger | 31 | 2011 | 1584 | 1.050 |
Why?
|
| Ecotoxicology | 3 | 2020 | 3 | 1.040 |
Why?
|
| Halogenated Diphenyl Ethers | 7 | 2018 | 9 | 0.990 |
Why?
|
| Drug and Narcotic Control | 2 | 2016 | 27 | 0.950 |
Why?
|
| Fetus | 9 | 2019 | 103 | 0.940 |
Why?
|
| Phthalic Acids | 7 | 2021 | 42 | 0.940 |
Why?
|
| Maternal-Fetal Exchange | 5 | 2020 | 32 | 0.920 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 159 | 0.870 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2020 | 663 | 0.850 |
Why?
|
| Cerebral Cortex | 10 | 2014 | 276 | 0.830 |
Why?
|
| Cytochrome P-450 CYP1A1 | 4 | 2014 | 13 | 0.810 |
Why?
|
| Risk Assessment | 17 | 2019 | 2116 | 0.800 |
Why?
|
| Consensus | 2 | 2019 | 174 | 0.800 |
Why?
|
| Nerve Tissue Proteins | 7 | 2004 | 430 | 0.800 |
Why?
|
| Female | 83 | 2024 | 34459 | 0.780 |
Why?
|
| Humans | 85 | 2024 | 65872 | 0.760 |
Why?
|
| Nervous System Diseases | 4 | 2019 | 109 | 0.720 |
Why?
|
| Thyroid Diseases | 5 | 2016 | 29 | 0.710 |
Why?
|
| Endocrinology | 5 | 2019 | 21 | 0.710 |
Why?
|
| Biomedical Research | 3 | 2016 | 264 | 0.680 |
Why?
|
| Dose-Response Relationship, Drug | 17 | 2015 | 859 | 0.650 |
Why?
|
| Public Health | 5 | 2016 | 188 | 0.650 |
Why?
|
| Research Design | 5 | 2010 | 589 | 0.640 |
Why?
|
| Toxicology | 4 | 2015 | 22 | 0.620 |
Why?
|
| Thyrotropin-Releasing Hormone | 10 | 2001 | 12 | 0.620 |
Why?
|
| Placenta | 2 | 2014 | 73 | 0.600 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 80 | 0.600 |
Why?
|
| Research | 2 | 2019 | 195 | 0.590 |
Why?
|
| Environmental Monitoring | 4 | 2018 | 155 | 0.580 |
Why?
|
| Policy | 1 | 2019 | 55 | 0.580 |
Why?
|
| Calmodulin-Binding Proteins | 4 | 2004 | 22 | 0.580 |
Why?
|
| Hypothalamo-Hypophyseal System | 8 | 2013 | 86 | 0.570 |
Why?
|
| Maternal Exposure | 7 | 2024 | 43 | 0.560 |
Why?
|
| Pregnancy Complications | 4 | 2023 | 390 | 0.530 |
Why?
|
| Embryonic and Fetal Development | 6 | 2004 | 46 | 0.510 |
Why?
|
| Perchlorates | 7 | 2012 | 7 | 0.500 |
Why?
|
| Neurosecretory Systems | 3 | 2015 | 24 | 0.500 |
Why?
|
| Gene Expression Regulation | 10 | 2011 | 1635 | 0.490 |
Why?
|
| Societies, Medical | 3 | 2015 | 401 | 0.490 |
Why?
|
| Chlorodiphenyl (54% Chlorine) | 4 | 2014 | 4 | 0.490 |
Why?
|
| Chemical Industry | 1 | 2016 | 8 | 0.490 |
Why?
|
| Pesticides | 5 | 2016 | 58 | 0.470 |
Why?
|
| Peer Review, Research | 1 | 2016 | 47 | 0.460 |
Why?
|
| Male | 59 | 2023 | 31435 | 0.460 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 129 | 0.450 |
Why?
|
| Health Impact Assessment | 1 | 2014 | 1 | 0.440 |
Why?
|
| Cost of Illness | 5 | 2016 | 169 | 0.430 |
Why?
|
| In Situ Hybridization | 12 | 2007 | 213 | 0.430 |
Why?
|
| Reproduction | 6 | 2016 | 100 | 0.420 |
Why?
|
| Organic Chemicals | 1 | 2014 | 27 | 0.410 |
Why?
|
| Gene Expression | 8 | 2007 | 858 | 0.410 |
Why?
|
| Food Safety | 2 | 2024 | 10 | 0.400 |
Why?
|
| Gonadotropin-Releasing Hormone | 8 | 1995 | 88 | 0.390 |
Why?
|
| Obesity | 4 | 2015 | 1279 | 0.370 |
Why?
|
| Estrogens, Non-Steroidal | 2 | 2010 | 38 | 0.370 |
Why?
|
| Ethanol | 6 | 2002 | 333 | 0.360 |
Why?
|
| Neurons | 9 | 2014 | 934 | 0.360 |
Why?
|
| Rats, Long-Evans | 7 | 2013 | 22 | 0.350 |
Why?
|
| Endocrine System Diseases | 4 | 2015 | 11 | 0.350 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 7 | 2007 | 19 | 0.350 |
Why?
|
| Fertility | 3 | 2016 | 85 | 0.350 |
Why?
|
| Xenobiotics | 2 | 2010 | 13 | 0.350 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2022 | 162 | 0.350 |
Why?
|
| No-Observed-Adverse-Effect Level | 3 | 2024 | 9 | 0.340 |
Why?
|
| Government Regulation | 4 | 2016 | 39 | 0.340 |
Why?
|
| Body Mass Index | 2 | 2018 | 903 | 0.340 |
Why?
|
| Animals, Newborn | 7 | 2014 | 241 | 0.340 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2016 | 50 | 0.330 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 408 | 0.330 |
Why?
|
| Hypothalamus | 9 | 1994 | 135 | 0.330 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 178 | 0.330 |
Why?
|
| Oligodendroglia | 2 | 2008 | 41 | 0.320 |
Why?
|
| Neurogranin | 6 | 2009 | 11 | 0.320 |
Why?
|
| Brain Chemistry | 5 | 2007 | 76 | 0.320 |
Why?
|
| Iodides | 2 | 2013 | 3 | 0.310 |
Why?
|
| Postmenopause | 3 | 2021 | 241 | 0.310 |
Why?
|
| Infant, Newborn | 7 | 2020 | 1441 | 0.290 |
Why?
|
| Salamandridae | 8 | 1988 | 8 | 0.290 |
Why?
|
| Public Health Practice | 1 | 2008 | 16 | 0.280 |
Why?
|
| Decision Making | 2 | 2013 | 430 | 0.280 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2008 | 45 | 0.280 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 3 | 1998 | 7 | 0.280 |
Why?
|
| Signal Transduction | 6 | 2011 | 3171 | 0.270 |
Why?
|
| Air Pollutants, Occupational | 2 | 2007 | 75 | 0.270 |
Why?
|
| Fetal Blood | 3 | 2018 | 73 | 0.270 |
Why?
|
| Infertility | 1 | 2008 | 30 | 0.260 |
Why?
|
| Myelin Basic Protein | 2 | 2000 | 20 | 0.260 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 170 | 0.260 |
Why?
|
| Vasotocin | 6 | 1988 | 6 | 0.250 |
Why?
|
| Fluorides | 2 | 2024 | 29 | 0.250 |
Why?
|
| Astrocytes | 1 | 2008 | 123 | 0.250 |
Why?
|
| Oxazoles | 1 | 2006 | 10 | 0.250 |
Why?
|
| Biomarkers | 5 | 2021 | 1506 | 0.250 |
Why?
|
| Herbicides | 3 | 2015 | 20 | 0.250 |
Why?
|
| Pregnancy, Animal | 1 | 2006 | 10 | 0.250 |
Why?
|
| Models, Biological | 5 | 2013 | 1193 | 0.250 |
Why?
|
| Inheritance Patterns | 1 | 2006 | 22 | 0.250 |
Why?
|
| Biological Assay | 1 | 2007 | 56 | 0.240 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2006 | 38 | 0.240 |
Why?
|
| Hydraulic Fracking | 2 | 2016 | 2 | 0.240 |
Why?
|
| Flame Retardants | 3 | 2016 | 6 | 0.240 |
Why?
|
| Homeodomain Proteins | 2 | 2005 | 277 | 0.230 |
Why?
|
| United States | 10 | 2023 | 8192 | 0.230 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2005 | 2 | 0.230 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2015 | 12 | 0.230 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2022 | 37 | 0.230 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2005 | 30 | 0.230 |
Why?
|
| Ethinyl Estradiol | 2 | 2019 | 9 | 0.230 |
Why?
|
| Corpus Callosum | 1 | 2005 | 42 | 0.230 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 1 | 2005 | 18 | 0.230 |
Why?
|
| Iodide Peroxidase | 4 | 2017 | 23 | 0.220 |
Why?
|
| Triclosan | 2 | 2017 | 9 | 0.220 |
Why?
|
| Body Weight | 5 | 2016 | 376 | 0.220 |
Why?
|
| Transcription Factors | 5 | 2011 | 1561 | 0.210 |
Why?
|
| Behavior, Animal | 3 | 2020 | 234 | 0.210 |
Why?
|
| Hearing Loss | 1 | 2005 | 56 | 0.210 |
Why?
|
| Sexual Behavior, Animal | 4 | 1988 | 88 | 0.210 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1391 | 0.210 |
Why?
|
| Prostate | 3 | 2020 | 124 | 0.200 |
Why?
|
| Water Pollutants, Chemical | 2 | 2019 | 43 | 0.200 |
Why?
|
| Child Behavior Disorders | 1 | 2004 | 38 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2005 | 351 | 0.200 |
Why?
|
| United States Food and Drug Administration | 2 | 2023 | 92 | 0.200 |
Why?
|
| Nuclear Proteins | 3 | 2011 | 793 | 0.200 |
Why?
|
| Vasoactive Intestinal Peptide | 4 | 2007 | 17 | 0.190 |
Why?
|
| Deficiency Diseases | 2 | 2013 | 12 | 0.190 |
Why?
|
| Environmental Health | 2 | 2016 | 14 | 0.190 |
Why?
|
| Drinking Water | 1 | 2023 | 21 | 0.190 |
Why?
|
| Cold Temperature | 4 | 2001 | 53 | 0.190 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 33 | 0.190 |
Why?
|
| Ovary | 2 | 2020 | 105 | 0.180 |
Why?
|
| Central Nervous System Depressants | 1 | 2002 | 46 | 0.180 |
Why?
|
| Lactation | 3 | 2013 | 77 | 0.180 |
Why?
|
| Suprachiasmatic Nucleus | 4 | 2007 | 122 | 0.180 |
Why?
|
| Alcoholism | 2 | 1996 | 329 | 0.180 |
Why?
|
| Receptors, Steroid | 1 | 2002 | 30 | 0.180 |
Why?
|
| Diabetes Mellitus | 3 | 2015 | 558 | 0.180 |
Why?
|
| Species Specificity | 5 | 2005 | 344 | 0.180 |
Why?
|
| Cerebellum | 3 | 2009 | 94 | 0.170 |
Why?
|
| In Vitro Techniques | 3 | 2020 | 491 | 0.170 |
Why?
|
| Policy Making | 1 | 2001 | 48 | 0.170 |
Why?
|
| Circadian Rhythm | 5 | 2007 | 365 | 0.170 |
Why?
|
| Radioimmunoassay | 8 | 2012 | 63 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 505 | 0.160 |
Why?
|
| Heart | 2 | 2020 | 298 | 0.160 |
Why?
|
| Bone Density | 1 | 2021 | 142 | 0.160 |
Why?
|
| National Institute of Environmental Health Sciences (U.S.) | 1 | 2020 | 1 | 0.160 |
Why?
|
| Adult | 14 | 2022 | 17595 | 0.150 |
Why?
|
| Food Contamination | 1 | 2020 | 24 | 0.150 |
Why?
|
| Pituitary Gland | 3 | 2007 | 50 | 0.150 |
Why?
|
| Receptors, Corticotropin | 1 | 2019 | 1 | 0.150 |
Why?
|
| Autoradiography | 8 | 2005 | 52 | 0.150 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 76 | 0.150 |
Why?
|
| Nucleic Acid Hybridization | 8 | 1991 | 100 | 0.150 |
Why?
|
| Urethra | 1 | 2020 | 77 | 0.150 |
Why?
|
| Enzyme Induction | 2 | 2011 | 25 | 0.150 |
Why?
|
| Hazardous Substances | 2 | 2020 | 16 | 0.150 |
Why?
|
| Food Packaging | 1 | 2020 | 34 | 0.150 |
Why?
|
| Child | 9 | 2022 | 4656 | 0.150 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 1720 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 99 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2020 | 96 | 0.150 |
Why?
|
| Arsenic | 1 | 2019 | 14 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2020 | 56 | 0.150 |
Why?
|
| United States Environmental Protection Agency | 3 | 2007 | 7 | 0.140 |
Why?
|
| Europe | 2 | 2016 | 200 | 0.140 |
Why?
|
| Cell Line | 3 | 2014 | 2032 | 0.140 |
Why?
|
| Iodine | 2 | 2022 | 21 | 0.140 |
Why?
|
| Interleukin-15 Receptor alpha Subunit | 1 | 2018 | 2 | 0.140 |
Why?
|
| Oligonucleotide Probes | 6 | 1997 | 41 | 0.140 |
Why?
|
| DNA Methylation | 1 | 2020 | 307 | 0.140 |
Why?
|
| Liver | 4 | 2018 | 879 | 0.130 |
Why?
|
| Rats, Inbred Strains | 10 | 1995 | 150 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2018 | 28 | 0.130 |
Why?
|
| Weight Gain | 1 | 2019 | 165 | 0.130 |
Why?
|
| Nucleic Acid Probes | 1 | 1997 | 2 | 0.130 |
Why?
|
| Ethylmaleimide | 1 | 1997 | 8 | 0.130 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 3 | 0.130 |
Why?
|
| Carbanilides | 1 | 2017 | 3 | 0.130 |
Why?
|
| Dioxins | 2 | 2014 | 17 | 0.130 |
Why?
|
| Thionucleotides | 1 | 1997 | 39 | 0.130 |
Why?
|
| Adolescent Behavior | 1 | 2019 | 195 | 0.130 |
Why?
|
| Gestational Age | 4 | 2002 | 198 | 0.130 |
Why?
|
| Hippocampus | 3 | 1998 | 277 | 0.130 |
Why?
|
| Mental Disorders | 2 | 2015 | 827 | 0.130 |
Why?
|
| Environment | 1 | 2017 | 125 | 0.120 |
Why?
|
| Pituitary Hormones | 1 | 2016 | 7 | 0.120 |
Why?
|
| Specimen Handling | 1 | 2017 | 61 | 0.120 |
Why?
|
| Organ Specificity | 4 | 2011 | 201 | 0.120 |
Why?
|
| Internet | 1 | 2020 | 472 | 0.120 |
Why?
|
| Androgens | 5 | 1999 | 67 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2007 | 606 | 0.120 |
Why?
|
| Peptides | 2 | 1991 | 593 | 0.120 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 154 | 0.110 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 54 | 0.110 |
Why?
|
| Placental Lactogen | 1 | 2014 | 1 | 0.110 |
Why?
|
| Prospective Studies | 5 | 2021 | 3340 | 0.110 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 119 | 0.110 |
Why?
|
| Human Growth Hormone | 1 | 2014 | 18 | 0.110 |
Why?
|
| Thyroid Function Tests | 1 | 2014 | 12 | 0.110 |
Why?
|
| Genes, jun | 1 | 1994 | 3 | 0.110 |
Why?
|
| Testis | 1 | 2015 | 162 | 0.110 |
Why?
|
| Pituitary Hormones, Posterior | 2 | 1987 | 2 | 0.110 |
Why?
|
| Myelin Proteins | 1 | 1994 | 30 | 0.110 |
Why?
|
| Genes, fos | 1 | 1994 | 18 | 0.110 |
Why?
|
| Congenital Hypothyroidism | 2 | 2019 | 12 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2014 | 1045 | 0.100 |
Why?
|
| Peptide PHI | 2 | 1991 | 2 | 0.100 |
Why?
|
| Embryo, Mammalian | 2 | 2005 | 159 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2022 | 1150 | 0.100 |
Why?
|
| Hospitals, General | 1 | 2013 | 18 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2006 | 1226 | 0.100 |
Why?
|
| Methimazole | 2 | 2010 | 8 | 0.100 |
Why?
|
| Preoptic Area | 4 | 1995 | 49 | 0.100 |
Why?
|
| Sex Factors | 2 | 2014 | 995 | 0.100 |
Why?
|
| Menopause | 1 | 2016 | 257 | 0.100 |
Why?
|
| Testosterone | 5 | 2015 | 128 | 0.100 |
Why?
|
| Spermatozoa | 1 | 2015 | 268 | 0.100 |
Why?
|
| Canada | 2 | 2024 | 157 | 0.100 |
Why?
|
| Time Factors | 7 | 2013 | 3780 | 0.100 |
Why?
|
| Gastrointestinal Hormones | 2 | 1991 | 10 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 1997 | 1980 | 0.090 |
Why?
|
| Mice | 10 | 2015 | 11183 | 0.090 |
Why?
|
| Intelligence | 1 | 2012 | 51 | 0.090 |
Why?
|
| Base Sequence | 5 | 1994 | 1332 | 0.090 |
Why?
|
| Models, Theoretical | 2 | 2016 | 274 | 0.090 |
Why?
|
| Somatostatin | 2 | 1992 | 21 | 0.090 |
Why?
|
| Animals, Wild | 2 | 2012 | 15 | 0.090 |
Why?
|
| Models, Animal | 2 | 2015 | 243 | 0.090 |
Why?
|
| Adolescent | 7 | 2019 | 6371 | 0.090 |
Why?
|
| Reproductive Medicine | 2 | 2009 | 5 | 0.090 |
Why?
|
| Health Policy | 1 | 2013 | 191 | 0.090 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2005 | 14 | 0.080 |
Why?
|
| Child Development | 1 | 2012 | 88 | 0.080 |
Why?
|
| Prolactinoma | 1 | 1991 | 4 | 0.080 |
Why?
|
| Orchiectomy | 1 | 1991 | 40 | 0.080 |
Why?
|
| Cell Count | 2 | 2008 | 128 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 1991 | 21 | 0.080 |
Why?
|
| Exercise | 1 | 2018 | 970 | 0.080 |
Why?
|
| Stress, Physiological | 2 | 1999 | 210 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1235 | 0.080 |
Why?
|
| Estradiol | 2 | 1989 | 260 | 0.080 |
Why?
|
| Seasons | 3 | 1986 | 140 | 0.080 |
Why?
|
| Breast | 1 | 2012 | 194 | 0.080 |
Why?
|
| Creatinine | 2 | 2021 | 136 | 0.080 |
Why?
|
| Genitalia, Female | 1 | 2010 | 16 | 0.080 |
Why?
|
| Depression, Chemical | 2 | 2004 | 11 | 0.080 |
Why?
|
| Superior Colliculi | 2 | 1988 | 12 | 0.080 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 878 | 0.080 |
Why?
|
| Smoking | 1 | 2014 | 864 | 0.080 |
Why?
|
| Xenopus laevis | 1 | 1989 | 72 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 26 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2024 | 2653 | 0.070 |
Why?
|
| Estrus | 1 | 1988 | 26 | 0.070 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1988 | 30 | 0.070 |
Why?
|
| Thyrotropin, beta Subunit | 1 | 2008 | 3 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2009 | 103 | 0.070 |
Why?
|
| Serum | 2 | 2019 | 27 | 0.070 |
Why?
|
| Phenylthiourea | 1 | 2008 | 2 | 0.070 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1987 | 3 | 0.070 |
Why?
|
| Ohio | 2 | 2020 | 24 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2008 | 42 | 0.070 |
Why?
|
| Malate Dehydrogenase | 1 | 2007 | 3 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2327 | 0.070 |
Why?
|
| Potassium Iodide | 1 | 2007 | 4 | 0.070 |
Why?
|
| Chronobiology Disorders | 1 | 2007 | 4 | 0.070 |
Why?
|
| Arginine Vasopressin | 1 | 2007 | 20 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2002 | 152 | 0.060 |
Why?
|
| North Carolina | 1 | 2007 | 69 | 0.060 |
Why?
|
| Phenyl Ethers | 1 | 2007 | 3 | 0.060 |
Why?
|
| Psychomotor Disorders | 1 | 2007 | 7 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 1987 | 28 | 0.060 |
Why?
|
| Cell Movement | 2 | 2014 | 484 | 0.060 |
Why?
|
| Brain Mapping | 2 | 2007 | 247 | 0.060 |
Why?
|
| Water Supply | 1 | 2006 | 16 | 0.060 |
Why?
|
| Rodentia | 1 | 2007 | 20 | 0.060 |
Why?
|
| Sex Determination Processes | 1 | 2006 | 11 | 0.060 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2006 | 5 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 117 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2006 | 18 | 0.060 |
Why?
|
| Genomic Imprinting | 1 | 2006 | 49 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 357 | 0.060 |
Why?
|
| Response Elements | 1 | 2006 | 41 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1299 | 0.060 |
Why?
|
| Luciferases | 1 | 2006 | 107 | 0.060 |
Why?
|
| Sulfur Radioisotopes | 2 | 1997 | 12 | 0.060 |
Why?
|
| Cluster Analysis | 1 | 2007 | 267 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1992 | 38 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2019 | 757 | 0.060 |
Why?
|
| Infant | 2 | 2012 | 1721 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 278 | 0.060 |
Why?
|
| Organ Size | 2 | 2016 | 175 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2006 | 257 | 0.060 |
Why?
|
| Homeostasis | 3 | 2004 | 383 | 0.060 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2005 | 14 | 0.060 |
Why?
|
| Dihydrotestosterone | 3 | 1983 | 21 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2006 | 146 | 0.060 |
Why?
|
| Motor Activity | 2 | 2007 | 347 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 197 | 0.060 |
Why?
|
| Aged | 5 | 2021 | 15155 | 0.060 |
Why?
|
| Myelin Sheath | 1 | 2005 | 39 | 0.060 |
Why?
|
| Transcription Factor HES-1 | 1 | 2005 | 7 | 0.060 |
Why?
|
| Random Allocation | 1 | 2005 | 200 | 0.060 |
Why?
|
| Tissue Distribution | 4 | 2001 | 292 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2005 | 126 | 0.050 |
Why?
|
| Tubulin | 1 | 2005 | 73 | 0.050 |
Why?
|
| Septal Nuclei | 1 | 2005 | 54 | 0.050 |
Why?
|
| Transfection | 1 | 2006 | 700 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2004 | 63 | 0.050 |
Why?
|
| Young Adult | 4 | 2018 | 4887 | 0.050 |
Why?
|
| Binding Sites | 2 | 2009 | 923 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2005 | 611 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2023 | 2090 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2010 | 716 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 690 | 0.050 |
Why?
|
| Feedback | 3 | 2007 | 91 | 0.050 |
Why?
|
| Wolffian Ducts | 1 | 1983 | 4 | 0.050 |
Why?
|
| Middle Aged | 5 | 2021 | 18518 | 0.050 |
Why?
|
| Sodium Compounds | 1 | 2003 | 1 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2007 | 475 | 0.050 |
Why?
|
| Norway | 1 | 2022 | 24 | 0.050 |
Why?
|
| Staphylococcal Protein A | 1 | 2002 | 5 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2002 | 37 | 0.050 |
Why?
|
| Selenium | 1 | 2022 | 27 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2002 | 56 | 0.050 |
Why?
|
| Corticosterone | 3 | 1988 | 24 | 0.050 |
Why?
|
| Autistic Disorder | 2 | 2015 | 160 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 1030 | 0.040 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2002 | 2 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2002 | 6 | 0.040 |
Why?
|
| Reference Values | 2 | 1994 | 330 | 0.040 |
Why?
|
| Animals, Suckling | 1 | 2001 | 1 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2192 | 0.040 |
Why?
|
| Protein Binding | 1 | 2006 | 1638 | 0.040 |
Why?
|
| Histocytochemistry | 4 | 1991 | 48 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 911 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2002 | 59 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 3507 | 0.040 |
Why?
|
| Mass Media | 1 | 2001 | 34 | 0.040 |
Why?
|
| Femur Neck | 1 | 2021 | 12 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 2021 | 17 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 542 | 0.040 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2021 | 47 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2021 | 76 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2021 | 80 | 0.040 |
Why?
|
| Osteoporotic Fractures | 1 | 2021 | 36 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2002 | 216 | 0.040 |
Why?
|
| Age Factors | 2 | 2007 | 1595 | 0.040 |
Why?
|
| Host Cell Factor C1 | 1 | 2000 | 2 | 0.040 |
Why?
|
| Gastrin-Releasing Peptide | 2 | 1991 | 3 | 0.040 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2000 | 3 | 0.040 |
Why?
|
| Imidazoles | 1 | 2000 | 82 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2001 | 201 | 0.040 |
Why?
|
| RNA Probes | 1 | 2000 | 9 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5477 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2014 | 327 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2002 | 962 | 0.040 |
Why?
|
| Plastics | 1 | 2020 | 22 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2018 | 396 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2742 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 127 | 0.040 |
Why?
|
| Aging | 1 | 2005 | 784 | 0.040 |
Why?
|
| Bangladesh | 1 | 2019 | 25 | 0.040 |
Why?
|
| Amphibians | 2 | 2012 | 27 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 45 | 0.040 |
Why?
|
| Neocortex | 1 | 1998 | 15 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 1999 | 59 | 0.040 |
Why?
|
| Women | 1 | 2018 | 44 | 0.030 |
Why?
|
| Women's Health | 1 | 2021 | 376 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 672 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2018 | 10 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2018 | 25 | 0.030 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 1997 | 2 | 0.030 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 1997 | 2 | 0.030 |
Why?
|
| Dihydroorotase | 1 | 1997 | 2 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 42 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 125 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2000 | 419 | 0.030 |
Why?
|
| Environmental Policy | 1 | 2017 | 3 | 0.030 |
Why?
|
| Body Composition | 1 | 2018 | 155 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 1997 | 19 | 0.030 |
Why?
|
| Cosmetics | 1 | 2017 | 17 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1997 | 87 | 0.030 |
Why?
|
| Multigene Family | 1 | 1997 | 106 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1997 | 173 | 0.030 |
Why?
|
| Iron-Binding Proteins | 1 | 2017 | 12 | 0.030 |
Why?
|
| Plasma | 1 | 2017 | 39 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2017 | 30 | 0.030 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 2 | 1988 | 18 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 453 | 0.030 |
Why?
|
| Phylogeny | 1 | 1997 | 400 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 106 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2016 | 53 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 187 | 0.030 |
Why?
|
| Autoantigens | 1 | 2017 | 140 | 0.030 |
Why?
|
| Protein Precursors | 2 | 2001 | 85 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 677 | 0.030 |
Why?
|
| Reproductive Health | 1 | 2016 | 25 | 0.030 |
Why?
|
| Sperm Count | 1 | 2015 | 14 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 527 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2016 | 102 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 28 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1995 | 27 | 0.030 |
Why?
|
| Sperm Motility | 1 | 2015 | 51 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2015 | 36 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 521 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 69 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 149 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 112 | 0.030 |
Why?
|
| Vasopressins | 2 | 1988 | 15 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2015 | 78 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 134 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 1997 | 443 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 88 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 281 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1995 | 154 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1994 | 34 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1994 | 52 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 208 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 1236 | 0.030 |
Why?
|
| San Francisco | 1 | 2013 | 10 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2013 | 24 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 147 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 47 | 0.020 |
Why?
|
| Maternal Age | 1 | 2013 | 35 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 230 | 0.020 |
Why?
|
| Phosphotransferases | 1 | 1993 | 22 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1993 | 46 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1997 | 719 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 178 | 0.020 |
Why?
|
| Castration | 3 | 1983 | 43 | 0.020 |
Why?
|
| Reflex, Startle | 1 | 2013 | 7 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 501 | 0.020 |
Why?
|
| Calibration | 1 | 2013 | 69 | 0.020 |
Why?
|
| Body Burden | 1 | 2012 | 12 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2012 | 2 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2012 | 26 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2012 | 9 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 289 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 788 | 0.020 |
Why?
|
| Atrazine | 1 | 2012 | 2 | 0.020 |
Why?
|
| Hypothermia | 1 | 1992 | 15 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 1992 | 21 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 1993 | 96 | 0.020 |
Why?
|
| Sexual Development | 1 | 2012 | 4 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2015 | 177 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2014 | 398 | 0.020 |
Why?
|
| Twins | 1 | 2012 | 52 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 1455 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2012 | 76 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1995 | 424 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 932 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 498 | 0.020 |
Why?
|
| Rats, Inbred BUF | 1 | 1991 | 10 | 0.020 |
Why?
|
| California | 1 | 2011 | 178 | 0.020 |
Why?
|
| Proestrus | 1 | 1990 | 4 | 0.020 |
Why?
|
| Oxytocin | 1 | 1990 | 44 | 0.020 |
Why?
|
| Thalamus | 1 | 1990 | 78 | 0.020 |
Why?
|
| Actins | 1 | 1990 | 265 | 0.020 |
Why?
|
| Hyperthyroidism | 1 | 2009 | 19 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1991 | 205 | 0.020 |
Why?
|
| Limbic System | 1 | 1988 | 28 | 0.020 |
Why?
|
| Sterilization, Reproductive | 1 | 1988 | 10 | 0.020 |
Why?
|
| Forecasting | 1 | 2009 | 231 | 0.020 |
Why?
|
| Hypertension | 1 | 1994 | 618 | 0.020 |
Why?
|
| Ovariectomy | 1 | 1988 | 104 | 0.020 |
Why?
|
| Dehydration | 1 | 1988 | 16 | 0.020 |
Why?
|
| Rats, Brattleboro | 1 | 1987 | 2 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1988 | 101 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 1988 | 35 | 0.020 |
Why?
|
| RNA, Heterogeneous Nuclear | 1 | 2007 | 1 | 0.020 |
Why?
|
| Hypothalamus, Anterior | 1 | 2007 | 4 | 0.020 |
Why?
|
| DNA | 2 | 1991 | 853 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2007 | 139 | 0.020 |
Why?
|
| Waste Management | 1 | 2006 | 1 | 0.020 |
Why?
|
| Chile | 1 | 2006 | 14 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 799 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 377 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 370 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 33 | 0.010 |
Why?
|
| Milk, Human | 1 | 2006 | 100 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2007 | 488 | 0.010 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1983 | 4 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1983 | 20 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 1983 | 17 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2007 | 715 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1983 | 49 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1999 | 901 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1983 | 106 | 0.010 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2001 | 1 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 564 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2001 | 16 | 0.010 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2001 | 8 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1983 | 209 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 184 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 426 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 451 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2001 | 161 | 0.010 |
Why?
|
| Transcortin | 1 | 1999 | 2 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1999 | 23 | 0.010 |
Why?
|
| Estrogens | 1 | 1999 | 115 | 0.010 |
Why?
|
| Neoplasms | 1 | 2009 | 1378 | 0.010 |
Why?
|
| Birth Weight | 1 | 1999 | 83 | 0.010 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 1997 | 29 | 0.010 |
Why?
|
| LIM Domain Proteins | 1 | 1997 | 32 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 1997 | 86 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1999 | 192 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1997 | 134 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 1997 | 96 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1997 | 365 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 417 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1997 | 869 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1999 | 745 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1997 | 345 | 0.010 |
Why?
|
| Amygdala | 1 | 1995 | 85 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1995 | 105 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 1590 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1994 | 5 | 0.010 |
Why?
|
| Rats, Inbred WKY | 1 | 1994 | 11 | 0.010 |
Why?
|
| Drinking | 1 | 1994 | 14 | 0.010 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 1993 | 8 | 0.010 |
Why?
|
| Brain Stem | 1 | 1993 | 30 | 0.010 |
Why?
|
| Reperfusion | 1 | 1993 | 38 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1993 | 45 | 0.010 |
Why?
|
| Calcium | 1 | 1995 | 587 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1994 | 537 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1991 | 44 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1991 | 301 | 0.010 |
Why?
|
| Sleep | 1 | 1991 | 246 | 0.000 |
Why?
|
| Ambystoma | 1 | 1986 | 2 | 0.000 |
Why?
|
| Trout | 1 | 1986 | 5 | 0.000 |
Why?
|
| Rana pipiens | 1 | 1986 | 10 | 0.000 |
Why?
|
| Anura | 1 | 1986 | 34 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 225 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1986 | 129 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1983 | 96 | 0.000 |
Why?
|